Frankfurt - Delayed Quote • EUR Agilent Technologies, Inc. (AG8.F) Follow 126.86 -0.68 (-0.53%) As of 8:20 AM GMT+2. Market Open. Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for AG8.F 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: AG8.F View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Reitmans (Canada) Limited Reports Fiscal 2024 and Fourth Quarter Fiscal 2024 Financial Results Agilent Technologies' (NYSE:A) earnings growth rate lags the 13% CAGR delivered to shareholders Agilent Receives Scientists' Choice Awards for Sustainability Agilent Receives European IVDR Class C Certification for GenetiSure Dx Postnatal Assay Waters (WAT) Boosts Waters Operating Segment With HPLC System Illumina CFO steps down amid executive shakeup Agilent (A) is Set for Analytica 2024 With Advanced Products Is Now An Opportune Moment To Examine Agilent Technologies, Inc. (NYSE:A)? Agilent (A) to Bolster DCG Segment With Upcoming Solutions Agilent Brings Great Science to Life at Analytica 2024 Agilent at AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics Agilent (A) Boosts LSAG Segment With Advanced Dilution System
